Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Hyaluronic Acid for Knee Osteoarthritis
NCT01270412Phase 3
Key facts
- Status
- Unknown
- Start
- Sep 2011
- Primary completion
- Dec 2012
- Countries
- 1
- Sponsor
- Meir Medical Center
- Modality
- Adoptive Cell Transfer
- Conditions
- osteoarthritis (OA)
01
Overview
Phase 3, randomised, double-blind trial of autologous platelet-rich plasma in osteoarthritis (OA) (2 arms), sponsored by Meir Medical Center. Primary endpoint: Improvement in pain, function, quality of life and activity level. Status: unknown.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Platelet Rich Plasma
Intra-articular injection 6ml of platelet-derived preparation rich in growth factors
Hyaluronic acid
Intra-articular injection 20 mg / 2 ml
03
Who it enrols
Patients aged 40-75 with diagnosed osteoarthritis of the knee for more than 1 year, without knee deformation.
04
Endpoints
Primary
Improvement in pain, function, quality of life and activity level
Beyond the preview
Go deeper on NCT01270412.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270412.